{"schema_version":"1","generated_at":"2026-11-03T02:54:55.861Z","data_as_of":null,"url":"https://www.findmykol.com/kol/clive-zent","json_url":"https://www.findmykol.com/kol/clive-zent/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"clive-zent","name":"Clive Zent","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"University of Rochester Medicine","institution_url":"https://www.findmykol.com/institution/university-of-rochester-medicine","city":"Rochester","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1225015662","orcid":"0000-0001-6099-3313","openalex":"A5059451077"},"summary":"Clive Zent is a Hematology physician affiliated with University of Rochester Medicine. OpenAlex indexes 319 publications with 9,196 citations (h-index 55); ClinicalTrials.gov lists 6 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":319,"cited_by_count":9196,"h_index":55,"latest_activity_year":2023,"source":"works"},"trials":{"count":6,"shown":3,"withheld":3,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01013961","title":"Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"ECOG-ACRIN Cancer Research Group","source_url":"https://clinicaltrials.gov/study/NCT01013961","trial_url":"https://www.findmykol.com/trial/NCT01013961"},{"nct":"NCT00935792","title":"Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Mayo Clinic","source_url":"https://clinicaltrials.gov/study/NCT00935792","trial_url":"https://www.findmykol.com/trial/NCT00935792"},{"nct":"NCT00669318","title":"Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Mayo Clinic","source_url":"https://clinicaltrials.gov/study/NCT00669318","trial_url":"https://www.findmykol.com/trial/NCT00669318"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2021,"amount_usd":68.97,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225015662"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1225015662","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Brukinsa","share_pct":48.7},{"name":"Calquence","share_pct":42.2},{"name":"Imbruvica","share_pct":4.9},{"name":"Jaypirca","share_pct":4.2}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2022,"last":2023},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21CA267040","title":"Re-designing anti-CD20 monoclonal antibody therapy using novel insights into limitations of innate immune cytotoxicity","fiscal_year":2023,"amount_usd":"176389","organization":"UNIVERSITY OF ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA267040"},{"project":"R21CA267040","title":"Re-designing anti-CD20 monoclonal antibody therapy using novel insights into limitations of innate immune cytotoxicity","fiscal_year":2022,"amount_usd":"215985","organization":"UNIVERSITY OF ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA267040"}],"source":"grants"},"contact":{"address_1":"601 ELMWOOD AVE","address_2":"BOX 704","city":"Rochester","state":"NY","zip":"146420001","phone":"585-273-5823","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1225015662","source":"identity"},"similar":[{"name":"Lisa Beck","slug":"lisa-beck","institution":"University of Rochester Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/lisa-beck","json_url":"https://www.findmykol.com/kol/lisa-beck/profile.json"},{"name":"Benzi Kluger","slug":"benzi-kluger","institution":"University of Rochester Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/benzi-kluger","json_url":"https://www.findmykol.com/kol/benzi-kluger/profile.json"},{"name":"Darren Tabechian","slug":"darren-tabechian","institution":"University of Rochester Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/darren-tabechian","json_url":"https://www.findmykol.com/kol/darren-tabechian/profile.json"},{"name":"Ayesa Mian","slug":"ayesa-mian","institution":"University of Rochester Medicine","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/ayesa-mian","json_url":"https://www.findmykol.com/kol/ayesa-mian/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-03-21","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}